Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-1998 | 06-1998 | |
| Sales | 141 | 0 |
| Gross Profit | 141 | N/A |
| Operating Income | 141 | N/A |
| Pre-tax Income | 141 | 0 |
| Net Income Continuous | -2,818 | -1,930 |
| Net Income | $-2,818 | $-1,930 |
| EPS Basic Total Ops | -0.12 | -0.09 |
| EPS Basic Continuous Ops | -0.12 | -0.09 |
| EPS Diluted Total Ops | -0.12 | -0.09 |
| EPS Diluted Continuous Ops | -0.12 | -0.09 |
| EBITDA(a) | $141 | $N/A |